Word

ZUNVIGO

Status

Pending

Status Code

730

Status Date

Tuesday, June 18, 2024

Serial Number

98009745

Mark Type

3

Filing Date

Tuesday, May 23, 2023

Published for Opposition

Tuesday, October 24, 2023

Trademark Owner History

Dizal (Jiangsu) Pharmaceutical Co., Ltd. - Owner At Publication

Classifications

5 Anti-cancer preparations; Biological preparations for the treatment of cancer; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer and tumor; Chemical reagents for medical or veterinary purposes; Chemical reagents for medical purposes; Mixed biological preparations for the prevention and treatment of infectious diseases; Pharmaceutical preparations for suppressing tumors; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations for the treatment of viral diseases; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical preparations for the treatment of human illnesses, namely, anti-tumor treatment; Pharmaceutical preparations, namely, antivirals; Pharmaceutical preparations, namely, appetite suppressants; Pharmaceutical preparations, namely, elixirs for the treatment of anti-tumor treatment and cancer; Pharmaceutical products for the prevention and treatment of cancer

The mark consists of the stylized wording "ZUNVIGO" with two double helix designs to the left of the wording.
Color is not claimed as a feature of the mark.
The wording ZUNVIGO has no meaning in a foreign language.

Trademark Events

May 26, 2023

New Application Entered

Jun 25, 2023

New Application Office Supplied Data Entered

Jun 27, 2023

Notice Of Design Search Code E-Mailed

Sep 14, 2023

Assigned To Examiner

Sep 19, 2023

Approved For Pub - Principal Register

Oct 4, 2023

Notification Of Notice Of Publication E-Mailed

Oct 24, 2023

Published For Opposition

Oct 24, 2023

Official Gazette Publication Confirmation E-Mailed

Dec 19, 2023

Noa E-Mailed - Sou Required From Applicant

Jun 18, 2024

Sou Teas Extension Received

Jun 18, 2024

Notice Of Approval Of Extension Request E-Mailed

Jun 18, 2024

Sou Extension 1 Granted

Jun 18, 2024

Sou Extension 1 Filed